Worthy Stocks Update: Forterra, Inc. (NASDAQ:FRTA), Calithera Biosciences, Inc. (NASDAQ:CALA)

Forterra, Inc. (NASDAQ:FRTA):

Last Trade:

Forterra, Inc. (NASDAQ:FRTA) ended its previous trading session at $3.76 with the Loss of -1.57%. The company’s market cap is $240.34 Million, and the average volume is $377.55 Million. The 52-Week High range of the stock is $12.3, while the 52-week low range is $3.25. The Price to Sales (P/S) of the stock is 0.16, while P/B (Price to Book) stands at 1.86. When we look at the Volatility of the company, Week Volatility is at 16.33% whereas Month Volatility is at 12.34%.


For the ongoing Fiscal Quarter, 3 analysts have an average earnings forecast of $-0.33 per share. According to the Analysts, the Low Earnings estimate for the current quarter is $-0.37, while the High earnings estimate is $-0.28.Comparatively, EPS for the same quarter last year was $0.


According to 2 analysts, the Average Revenue Estimate for the current Fiscal quarter is $291.83 Million and the Low Revenue estimate is $288.4 Million, while the High Revenue estimate is $295.27 Million.


Forterra, Inc. (NASDAQ:FRTA) analysts on average have given a price target of $7.08 on FRTA stock.


According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 2.9 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.


Calithera Biosciences, Inc. (NASDAQ:CALA):


Previous Trade:

Calithera Biosciences, Inc. (NASDAQ:CALA) shares Jumped 4.16% and ended the day at $4.01. Its 52-week high and low range is between $9.35 and $3.55. The company’s outstanding shares are 37.1 Million. The volume of the company in the last trading session was 370286. The stock has a market cap of 148.77 Million. The Stock shows P/E value of 0 and Forward P/E of 0.


According to Finviz reported data, The SMA20 of the stock is at -10.33%, SMA50 is -16.21 percent, while SMA200 is -23.26%. The stock is currently has its Return on Assets (ROA) value of -27.2 Percent. The Return on Investment and Return on Equity (ROE) values are -19.8 percent and -31.7 percent, respectively.


The company’s ATR (Average True Range) is 0.29. The Weekly Volatility is 7.13% and the Monthly Volatility is 6.68%.


When we look at the Analyst Recommendations of the stock, the company has 1.2 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.


Calithera Biosciences, Inc. (NASDAQ:CALA) analysts on average have given a price target of $7.08 on CALA stock.


Calithera Biosciences, Inc.’s Average Earnings Estimate for the current quarter is $-0.47, according to consensus of 2 analysts. The low EPS estimate is $-0.56, while the high EPS estimate is $-0.39.


Average Revenue Estimate of the company for the current Fiscal Quarter is $3 Million, according to consensus of 2 analysts. The higher end of the revenue estimate is $6 Million and the lower end is $0.

SHARE

LEAVE A REPLY